tradingkey.logo

Insulet Corp

PODD
View Detailed Chart

304.630USD

+1.010+0.33%
Close 06/13, 16:00ETQuotes delayed by 15 min
21.43BMarket Cap
51.24P/E TTM

Insulet Corp

304.630

+1.010+0.33%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.33%

5 Days

-2.29%

1 Month

-5.40%

6 Months

+13.10%

Year to Date

+16.69%

1 Year

+51.97%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 25 analysts
BUY
Current Rating
336.918
Target Price
10.60%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

112
Total
7
Median
9
Average
Company name
Ratings
Analysts
Insulet Corp
PODD
25
Medtronic PLC
MDT
34
Stryker Corp
SYK
33
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
28
Dexcom Inc
DXCM
27
1
2
3
...
23

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(4)
Neutral(4)
Buy(5)
Indicators
Sell(2)
Neutral(4)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-9.047
Neutral
RSI(14)
49.216
Neutral
STOCH(KDJ)(9,3,3)
26.020
Neutral
ATR(14)
6.940
Low Volatility
CCI(14)
-82.865
Neutral
Williams %R
72.959
Sell
TRIX(12,20)
0.270
Sell
StochRSI(14)
98.756
Buy
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
302.976
Buy
MA10
311.126
Sell
MA20
317.762
Sell
MA50
285.678
Buy
MA100
278.308
Buy
MA200
262.809
Buy

News

More news coming soon, stay tuned...

Company

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.
Ticker SymbolPODD
CompanyInsulet Corp
CEOMs. Ashley Mcevoy
Websitehttps://www.omnipod.com
KeyAI